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Introduction 
Most researchers now acknowledge that stuttering is a multidimensional disorder 
(Smith & Kelly, 1997). Therefore, any assessment of stuttering treatment requires a 
multifaceted approach. A multifaceted approach typically includes assessing both surface 
elements as well as elements of stuttering that exist “below the surface.” Surface 
elements include aspects of the core behavior of stuttering such as stuttering frequency 
and stuttering moment durations. Elements that exist “below the surface” include 
symptomatic aspects of stuttering such as speaking avoidance, reduced social and 
occupational participation, and negative affective functioning in areas like locus of 
control, mood, and anxiety. Because there is often disagreement regarding the essential 
components of stuttering treatment there is also disagreement about appropriate treatment 
outcome measures (Blomgren, Roy, Callister, & Merrill, 2006a; Blomgren, Roy, 
Callister, & Merrill, 2006b; Reitzes & Snyder, 2006; Ryan, 2006). This article aims to 
summarize some of the issues of conducting a multidimensional appraisal of stuttering 
treatment. 
Levels of Treatment Outcomes Measurement 
 The first step in any stuttering treatment outcomes assessment is determining the 
type of assessment to be conducted.  Treatment outcome studies may be categorized into 
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1998). The most basic level is treatment effectiveness research. Treatment effectiveness 
research evaluates a clinical treatment primarily on the stated goals of the treatment. 
Treatment effectiveness studies report whether a treatment does what it advertises to do. 
Depending on the type of treatment (i.e., stuttering modification or fluency shaping), the 
measures used may differ considerably. The next level of assessment is treatment 
outcomes research. Treatment outcomes research evaluates clinically relevant outcomes 
of a normally prescribed (typical) treatment. More than simply evaluating stated goals, 
treatment outcome studies throw a broader evaluative net. Treatment outcomes research 
may measure both intended and unintended outcomes, (i.e., consequences) of a treatment. 
Typically treatment outcomes research involves areas of importance to those afflicted by 
a disorder, regardless of the actual, or stated, goals of the treatment. Finally, treatment 
efficacy research assesses the degree to which a treatment is helpful under experimental, 
or ideal, conditions. Treatment efficacy research is the most involved level of assessment 
and typically includes comparisons of different treatments and/or includes measurements 
of treatment efficiency. Measuring treatment efficiency is to examine dose-response 
relationships in treatment. In other words, treatment efficiency relates changes in the 
benefits of a treatment given different treatment durations. The gold standard of treatment 
efficacy research is the prospective randomized clinical trial. In this research paradigm, 
subjects are randomly assigned to two or more treatment (or non-treatment) conditions. 
In a stuttering outcomes assessment, the level of outcomes measurement should be 
transparent.  
What to Measure and Why 
The World Health Organization ([WHO] 2001) has advocated a multidimensional 
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“disability” and “handicap” with the concepts of “impairment,” “activity limitation,” and 
“participation restrictions.” This viewpoint is particularly relevant to the complex and 
multifaceted disorder of stuttering. The WHO model has been utilized for assessing both 
core, or surface, stuttering behavior (the “impairment”) and the undesirable, or “below 
the surface” consequences of stuttering (the “activity limitations and participation 
restrictions”) (e.g., American Speech-language-Hearing Association, 2001; Finn, 
Howard, & Kubala, 2005; Yaruss, 2001; Yaruss & Quesal, 2004). Any holistic 
assessment of the success of a stuttering treatment should use a multidimensional 
approach that includes both impairment and participation restrictions / activity 
limitations. 
A treatment outcomes study will only be as good as the data collected. The first 
step in data collection is choosing appropriate measurement tools. Measurement tools that 
can be used to evaluate stuttering treatment are numerous. Decisions on which particular 
instruments to use will be driven by beliefs about the essential outcomes of stuttering 
treatment. Ultimately, measures should be chosen based on their ability to elucidate 
factors that are thought to be important outcomes of stuttering treatment.  
Symptoms of stuttering have often been categorized into three types. Guitar 
(1998) lists three primary components of stuttering: core behaviors, secondary behaviors, 
and affective aspects of stuttering. Bennet (2006) has written about the ABCs of 
stuttering which include affective components, behavioral components, and cognitive 
components.  Minimally, a comprehensive treatment outcomes study should provide 
adequate measurement on both the surface (behavioral) and subsurface (cognitive and 
affective) aspects of the disorder. Further, when appropriate, it is recommended to assess 

















anuscript          
University of Utah Institutional Repository  
Author Manuscript 
 4 
include both observer-reported and self-reported data. Multiple measures can (a) provide 
the essential multidimensional analysis of stuttering treatment, (b) provide for an 
assessment of the convergent validity of the findings (i.e., the degree to which similar 
findings are obtained using different measures of the constructs), and (c) enhance the 
applicability of the results to the research of others (Blomgren, Roy, Callister, & Merrill, 
2005).   
Treatment Outcomes and The University of Utah Intensive Stuttering Clinic 
At The University of Utah, we are currently collecting outcomes data on our ten-
day fluency facilitation program, The University of Utah Intensive Stuttering Clinic 
(UUISC). The clinic involves approximately 65 hours of direct treatment. The clinic runs 
from 9 a.m. to 4:30 p.m., Monday through Friday, for two weeks. Therapy includes a 
combination of individual and group sessions.  Each clinic typically comprises five to 
eight clients. This is an annual clinic and the fourth clinic was completed in August of 
2007.  
The UUISC is principally a prolonged speech / fluency shaping approach to 
stuttering treatment. The primary goal of the clinic is to have clients learn and apply 
speech motor techniques that facilitate fluent speech. These techniques include prolonged 
speech, gentle vocal onsets, and reduced articulatory pressure. Approximately 80% of the 
clinic time is devoted to fluency skill acquisition. The UUISC is based on the fluency 
shaping approach developed by Webster (1982). Additional fluency shaping influences 
come from Boberg and Kully (1985). The UUISC is also an example of an eclectic 
approach to stuttering treatment. In addition to fluency facilitation, stuttering 
modification techniques and issues related to stuttering management, stuttering 
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Specifically, these secondary goals of the clinic include stuttering management 
techniques such as disclosure of stuttering, managing speaking related anxiety, and 
techniques for terminating moments of stuttering when they occur. Some of the 
cognitive-behavioral and desensitization approaches were influenced by Breitenfeldt and 
Lorenz (1989), Kroll (1991), and Webster and Poulos (1989). The treatment manual is 
available through XanEdu Custom Publishing (Blomgren, 2005) or through the author 
(michael.blomgren@health.utah.edu).  
We are currently analyzing the treatment outcomes data from the past four years 
of the clinic. To date, twenty-two people who stutter have attended the clinic. Preliminary 
group outcomes data suggests substantial decreases in stuttering frequency immediately 
post-treatment, with a mild regression of gains six months to two years post-treatment. 
While we are currently in the midst of these analyses, one clear observation is that the 
individual data are highly variable in respect to changes in the various outcome 
measurements. Additionally, some clients have been exceptional skill maintainers, while 
a small group has clearly struggled to maintain their immediate post-treatment gains. The 
following section provides an overview of the data we are collecting and the rationale for 
its inclusion. The list is not intended to serve as an exhaustive compilation, but is simply 
provided as one example of conducting a multidimensional stuttering treatment outcomes 
study. Our outcomes data on this fluency shaping program is similar to the battery we 
used in our published outcomes assessment of a stuttering modification program 
(Blomgren et al., 2005). 
1. Assessment of Speech & Stuttering. Assessment of frequency and severity of 
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to assess dimensions of the behavior that defines the disorder should be fairly self-
evident.  
a. Observer calculated stuttering frequency. Percentage of stuttered syllables is 
calculated during:  
i. Two reading passages 
ii. A five-minute monologue 
iii. Two out-of-clinic speaking situations. 
b. Two self-assessed stuttering severity ratings. Clients are asked to self-assess 
their stuttering severity on an 8-point scale (0=no stuttering, 7=severe 
stuttering). Clients self-assess their stuttering immediately following a five-
minute monologue and additionally provide an estimate of their perceived 
average stuttering severity over the past two weeks. 
c. Average duration of three longest moments of stuttering calculated for each 
speaking situation. 
d. Scores on the Stuttering Severity Instrument for Children and Adults, Third 
Edition (SSI-3; Riley, 1994). 
e. Speech rate as a function of syllables per minute. 
f. Articulation rate as a function of average fluent word durations in msec.  
g. A speech naturalness rating scale (Martin, Haroldson, & Triden, 1984). This is 
a 9-point scale where raters judge a speech sample based on a gestalt notion of 
“natural” vs. “unnatural” speech production. Assessing speech naturalness is 
important because if post-treatment speech continues to be unnatural, it is 
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2. Assessment of Secondary Stuttering Behaviors. Secondary, or concomitant, stuttering 
behaviors often present as much (or more) a part of the stuttering problem as the core 
behaviors. Appropriate evaluation of this aspect of stuttering provides for a 
considerably more complete evaluation of stuttering behavior than simple stuttering 
frequency counts. 
a. Measured via “physical concomitants” subscale score from the SSI-3 
b. Perceptions of Stuttering Inventory (PSI; Woolf, 1967). This 60-item 
inventory assesses three dimensions of stuttering: (a) self-assessed struggle to 
speak, (b) avoidance behaviors, including efforts to avoid both situations and 
words in which an individual anticipates stuttering and (c) expectancy of 
stuttering and expectations about one’s ability to speak successfully. 
3. Affective Measures. For many people who stutter, the disorder has innumerable 
psychological consequences. Assessment of the following areas may provide insight 
into positive affective changes arising from improved speech production and / or 
improved management of stuttering. 
a. Anxiety – Nearly every person who stutters reports feelings of increased 
anxiety when speaking, especially in situations involving strangers, groups, 
and the telephone. Measuring aspects of anxiety can be an important ancillary 
measure of treatment success. We measure anxiety using two scales: 
i. Liebowitz Social Anxiety Scale (Liebowitz, 1987). Nearly all of the 24 
items on this scale relate to communication. Scores are obtained for 
both “fear or anxiety” and “avoidance.” 
ii. The Multi-Component Anxiety Inventory (MCAI-IV; Schalling, 
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assessment of anxiety into three subscales: Psychic/Cognitive Anxiety, 
Somatic Anxiety, and Muscular Tension. Previous research has 
indicated this scale to be a sensitive marker of stuttering treatment 
effectiveness (Blomgren et al., 2005). 
b. Mood - Measured with the Beck Depression Inventory (BDI; Beck & Steer, 
1993). The BDI was designed to reveal a general syndrome of depression, but 
has also been used for assessing subclinical changes in mood. It assumed 
(albeit unproven) that improved control over speech production may lead to 
positive changes in mood.   
c. Feelings of control - Measured with the Locus of Control of Behavior Scale 
(LCB: Craig, Franklin, & Andrews, 1984). The LCB assesses the extent to 
which individuals perceive responsibility for their own problem behavior. 
Lower LCB scores indicate a more internal locus of control. Changes in locus 
of control have been reported to predict maintenance of therapeutic gains or 
relapse in stuttering therapy (Craig & Andrews, 1985). 
4. Effect of Stuttering in Daily Situations and on Quality of Life in General. 
Measurement in this area allows for assessment of possible changes in “activity 
limitations,” and “participation restrictions.” 
a. The Overall Assessment of the Speaker’s Experience of Stuttering (OASES; 
Yaruss & Quesal, 2006) includes assessment of a speaker’s knowledge about 
their stuttering, reactions to their stuttering, level of difficulty communicating 
in daily situations, and impact of stuttering on quality of life, social 
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The above list is an example of a relatively robust treatment outcomes collection strategy. 
Due to the large amount of time and effort involved in collecting and analyzing data of 
this magnitude, this particular “catch-all” strategy is most applicable to a funded research 
environment. It may well be possible to capture the essence of this larger outcomes study 
by using fewer measurement tools. For speech-language pathologists engaged in a busy 
clinical practice, a more succinct, more clinically “doable,” strategy might be to collect 
both surface and subsurface treatment outcomes data using only three or four 
measurement tools. One “time friendly” example would be to collect pretreatment, 
posttreatment, and follow-up treatment data utilizing: (1) the SSI-3 (reporting stuttering 
frequency, the SSI-3 subscores, and the overall SSI-3 score), (2) the PSI (reporting the 
three struggle, avoidance, and expectancy subscores), (3) a client-reported stuttering 
severity measure, and perhaps (4) the OASES.  
Conclusions 
Obtaining valid and robust stuttering treatment outcomes takes planning and 
requires many decisions regarding appropriate outcome measurements. Those measures 
should always include an assessment of both the overt or surface aspects of stuttering and 
the important subsurface aspects of stuttering that often contribute to severity of the 
impairment. The practice of evidence-based stuttering therapy implies that we have 
collected data and have adequate proof of success to promote a particular treatment 
(Ingham, 2003; Onslow, 2003). It is an issue of “truth in advertising.” Are we really 
providing the quality of service that we hope or believe we are? And, are the positive 
results that are often reported immediately following a stuttering treatment program 
durable? Long term follow-up data are also needed. It is imperative that the field of 
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